Outlook Therapeutics issues warrants in $55 million stock offering priced at $0.99 per share
OTLK•Outlook Therapeutics prices $55 million offering
Outlook Therapeutics priced an underwritten offering of 55,555,556 shares with warrants for up to 55,555,556 shares at $0.99 per share.
- Warrants carry a $1.10 exercise price, become exercisable immediately, and expire five years from issuance.
- Gross proceeds are expected to be about $55 million, excluding any warrant exercises.
- Underwriters hold a 30-day option for up to 8,333,333 additional shares or warrants at the offering price.
- Closing is expected Aug. 14, 2026.
